Cash-strapped Zoono seeks A$2.1m from rights issue

Cash-strapped Zoono seeks A$2.1m from rights issue
Hand and surface sanitisers were in demand during the pandemic. (Image: Getty)
Denise McNabb
After continuing to burn cash and as its revenue plunges, Zoono Group plans to raise A$2.1 million (NZ$2.2m) through a pro-rata rights issue with free options to fund projects, a joint venture with Douglas Pharmaceuticals, China expansion and working capital. The Australian stock exchange-listed New Zealand manufacturer of antimicrobial hand and surface sanitisers announced the share offer in tandem with the release of its March 31 third-quarter report.The report details a dire future for the company unless it changes direction away from e...

More Markets

NZ Super Fund's $745m active windfall
Markets

NZ Super Fund's $745m active windfall

The super fund now has more than $85 billion under its control.

Analysts cautious after KMD Brands strategic reset
Markets

Analysts cautious after KMD Brands strategic reset

Analysts say the operating backdrop remains challenging. 

Contact Energy lodges fast-track application for windfarm
Infrastructure

Contact Energy lodges fast-track application for windfarm

The Southland project was rejected under a different fast-track process six months ago.